Correlation Between Pmv Pharmaceuticals and ATyr Pharma
Can any of the company-specific risk be diversified away by investing in both Pmv Pharmaceuticals and ATyr Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pmv Pharmaceuticals and ATyr Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pmv Pharmaceuticals and ATyr Pharma, you can compare the effects of market volatilities on Pmv Pharmaceuticals and ATyr Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pmv Pharmaceuticals with a short position of ATyr Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pmv Pharmaceuticals and ATyr Pharma.
Diversification Opportunities for Pmv Pharmaceuticals and ATyr Pharma
0.03 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Pmv and ATyr is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Pmv Pharmaceuticals and ATyr Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ATyr Pharma and Pmv Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pmv Pharmaceuticals are associated (or correlated) with ATyr Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ATyr Pharma has no effect on the direction of Pmv Pharmaceuticals i.e., Pmv Pharmaceuticals and ATyr Pharma go up and down completely randomly.
Pair Corralation between Pmv Pharmaceuticals and ATyr Pharma
Given the investment horizon of 90 days Pmv Pharmaceuticals is expected to generate 0.85 times more return on investment than ATyr Pharma. However, Pmv Pharmaceuticals is 1.18 times less risky than ATyr Pharma. It trades about -0.04 of its potential returns per unit of risk. ATyr Pharma is currently generating about -0.04 per unit of risk. If you would invest 989.00 in Pmv Pharmaceuticals on August 24, 2024 and sell it today you would lose (828.00) from holding Pmv Pharmaceuticals or give up 83.72% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 76.81% |
| Values | Daily Returns |
Pmv Pharmaceuticals vs. ATyr Pharma
Performance |
| Timeline |
| Pmv Pharmaceuticals |
| ATyr Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Pmv Pharmaceuticals and ATyr Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pmv Pharmaceuticals and ATyr Pharma
The main advantage of trading using opposite Pmv Pharmaceuticals and ATyr Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pmv Pharmaceuticals position performs unexpectedly, ATyr Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ATyr Pharma will offset losses from the drop in ATyr Pharma's long position.| Pmv Pharmaceuticals vs. Eliem Therapeutics | Pmv Pharmaceuticals vs. MediciNova | Pmv Pharmaceuticals vs. Pharvaris BV | Pmv Pharmaceuticals vs. PepGen |
| ATyr Pharma vs. Mereo BioPharma Group | ATyr Pharma vs. Terns Pharmaceuticals | ATyr Pharma vs. PDS Biotechnology Corp | ATyr Pharma vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |